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Purpose of the study
To assess the accuracy of a sonographic based grading
scale (US-GS) in identification of body fat changes (BFCs)
related to lipoatrophy (LA) in HIV patients treated with
antiretrovirals, compared with the HIV Outpatient Study
(HOPS) based clinical diagnoses.
Methods
We enrolled non-obese HIV patients (73 males and 42
females; body mass index <27 kg/m2). Clinical assess-
ments of BFCs were defined by correspondence between
the self-reports of patients and medical examinations. Fat
redistribution was scored separately for face, arm and
lower limbs on a scale ranging from 0 (absence) to 1
(mid) and 2–3 (severe BFCs). US scans of subcutaneous
fat thickness (SFT) were performed at 3 reference points:
transversal scan at the deepest point of Bichat pad (facial
SFT), long dorsal scan of arm (brachial SFT), and long
scan of anterior face of thigh (crural SFT).
Summary of results
There were no significant differences in demographics
(age, body mass index) or clinical features (CD4 T lym-
phocytes, duration of HIV infection and duration of
HAART) between males or females with no LA (HOPS
grading scale 0), or those with mid LA (HOPS grading
scale 1) or severe LA (HOPS grading scale 2–3). Signifi-
cant differences were found in US assessments for each
corresponding HOPS-GS (p ranged from <0.03 to
0.0004). Diagnostic thresholds were identified for the
assessment of each degree of LA severity (US-GS 0 vs. US-
GS 1 and US-GS 2–3) for facial, brachial and crural LA,
with related sensitivity (range: 70–99%), specificity
(range: 70–95%), positive likelihood ratios (range: 2.83–
11.2) and negative likelihood ratios (range: 0.07–0.41). A
logistic regression showed that the US-GS correctly diag-
nosed the 80.9% of all cases of LA (regression coefficient:
2.1 (SE: 0.54), p < 0.0001) with an odds ratio of 8.1 (95%
CI: 2. 8 to 23.5).
Conclusion
US shows significant correlation with the HOPS based
assessments. Significant areas under the ROC curves, dis-
tinct diagnostic thresholds with high sensitivity, specifi-
city and likelihood ratios suggest that US is reliable for the
diagnosis of LA. Compared to the HOPS, the US-GS
shows high percentages of correctly classified cases of LA.
Serial assessments could identify early BFCs related to
HAART or be used to prevent advanced stages. It could
suggest the need for proactive switching therapies or iden-
tify the SFT recovery in response to reactive switching ther-
apies.
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